Universal Scientific Industrial (Shanghai) Co., Ltd.

SSE:601231.SS

14.06 (CNY) • At close May 16, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

20242023202220212020201920182017201620152014201320122011201020092008
Revenue 60,690.65160,791.9168,516.07655,299.65547,696.22837,204.18833,550.27529,705.68523,983.88421,323.07715,873.00114,272.34713,335.29512,707.5913,707.8110,687.31814,331.956
Cost of Revenue 54,929.61355,169.36561,327.07549,981.47942,710.9733,499.41129,907.52326,428.47821,398.21819,093.43313,804.62112,570.72811,670.54811,243.92112,136.2669,401.83812,960.394
Gross Profit 5,761.0385,622.5447,189.0015,318.1764,985.2583,704.7773,642.7523,277.2072,585.6662,229.6452,068.381,701.6191,664.7471,463.6691,571.5441,285.481,371.562
Gross Profit Ratio 0.0950.0920.1050.0960.1050.10.1090.110.1080.1050.130.1190.1250.1150.1150.120.096
Reseach & Development Expenses 1,907.551,807.2042,034.4621,641.3991,576.3631,372.6061,312.4761,018.995884.295915.003691.528569.493529.7190000
General & Administrative Expenses 358.8981,215.428278.547294.535208.311221.19193.16586.737103.26254.68843.6332.51674.33959.39546.09271.99586.88
Selling & Marketing Expenses 68.632367.995323.834311.481318.472320.479280.444240.144223.677225.404279.293217.944210.674234.844249.849233.427410.065
SG&A 427.5311,563.924602.381606.016526.783541.67373.609326.881326.939280.092322.923250.46285.013294.239295.941305.423496.945
Other Expenses 1,553.47673.7381,142.587873.778899.777543.0266.646140.68952.16429.66620.68619.46325.89620.2464.63319.7775.782
Operating Expenses 3,888.5563,444.8663,779.433,121.1923,002.9232,457.3022,208.0581,892.4381,658.2871,556.3411,334.0121,085.596901.81915.229947.762894.1321,140.694
Operating Income 1,872.4822,177.6783,460.8042,131.8131,961.6511,422.1511,386.6731,564.791990.572738.054798.89616.531742.82526.894624.437375.88389.693
Operating Income Ratio 0.0310.0360.0510.0390.0410.0380.0410.0530.0410.0350.050.0430.0560.0410.0460.0350.006
Total Other Income Expenses Net -18.66512.0116.3917.04511.91210.6126.646-0.90223.64120.76412.27814.64120.25517.265-30.5097.2371.844
Income Before Tax 1,853.8172,189.6883,477.1952,138.8591,973.5631,432.7631,393.321,564.4261,007.351757.553811.167631.172763.075544.16627.634383.1291.538
Income Before Tax Ratio 0.0310.0360.0510.0390.0410.0390.0420.0530.0420.0360.0510.0440.0570.0430.0460.0360.006
Income Tax Expense 209.647239.979417.205282.166239.998172.655213.352250.335201.08567.036109.77366.959115.74192.488.99469.07361.393
Net Income 1,652.4831,947.8473,059.9671,857.9681,739.4351,262.1041,179.7151,313.89805.582761.119701.394564.213647.334451.759538.64314.04730.144
Net Income Ratio 0.0270.0320.0450.0340.0360.0340.0350.0440.0340.0360.0440.040.0490.0360.0390.0290.002
EPS 0.760.891.40.850.80.580.540.60.370.350.340.280.330.250.30.180.015
EPS Diluted 0.760.871.350.830.80.580.540.60.370.350.340.280.330.250.30.180.015
EBITDA 3,544.8343,822.0764,716.1633,392.5782,722.5342,088.9861,868.0512,046.1521,584.8141,245.5741,078.119858.926985.992803.182889.706705.124514.694
EBITDA Ratio 0.0580.0630.0690.0610.0570.0560.0560.0690.0660.0580.0680.060.0740.0630.0650.0660.036